BioCentury
ARTICLE | Clinical News

TAP reports Phase III Spectracef data

September 18, 2000 7:00 AM UTC

TAP Pharmaceuticals (Deerfield, Ill.) said that in a Phase III study of its Spectracef cefditoren pivoxil oral cephalosporin antibiotic to treat acute bacterial exacerbations of chronic bronchitis, th...